Search Results for: mayo clinic

Let’s Talk About NET Survivorship: An Evening for Neuroendocrine Cancer Patients and Caregivers

“Let’s Talk About NET Survivorship!” is a special evening presentation for neuroendocrine cancer patients and caregivers and their health care providers.  Attend in person at the Grand Hotel Minneapolis in Minneapolis, Minnesota…

2019 Chicago Neuroendocrine Tumor Conference

The 2019 Chicago Neuroendocrine Tumor (NET) Patient and Caregiver Education Conference will offer educational and networking opportunities for people living with NETs, their caregivers, family members, and friends. Educational sessions and panel…

NE FL Neuroendocrine Cancer Zebras

What

A Mayo Clinic support group started by a patient to discuss general information about Neuroendocrine Cancer. A Mayo Clinic Social Work facilitator will provide support and guide conversation on both patient and caregiver relevant topics. A Mayo…

NANETS Regional NET Education, Phoenix

Jointly provided by Banner MD Anderson Cancer Center and the North American Neuroendocrine Tumor Society, NANETS, The Multidiscplinary Management of NET Cancers, a CME/CE Certified Activity, will be presented on Saturday, March 16, 2019 at the Scottsdale…

Frankly Speaking about Cancer: Neuroendocrine and Carcinoid Tumors Workshops

Seven Frankly Speaking about Cancer: Neuroendocrine and Carcinoid Tumors Workshops will be hosted by the Cancer Support Community (CSC) through its Affiliate network across the country in November and December. All are free to attend and many will …

Peptide Receptor Radionuclide Therapy, PRRT: Updates and Locations

Since we shared the news of the FDA’s January 26, 2018 approval of peptide receptor radionuclide therapy, PRRT, with Lutathera  (lutetium Lu 177 dotatate), more information has become available for the neuroendocrine tumor community, including updates…

Gallium 68 PET/CT Scanning for Neuroendocrine Tumors — Information and Locations (updated January 26, 2019)

The US Food and Drug Administration’s (FDA) June 1, 2016 approval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT® heralded a new age of nuclear imaging for neuroendocrine tumors in the United States.

The Role of Sandostatin Analogue in the Reduction of Tumor Growth

Presented by Eugene Woltering, M.D.
Louisiana State University Medical Center, New Orleans, Louisiana

Carcinoid Symposium
Sarasota, Florida
May 11, 2000

It’s all in the packaging, guys.  Can we sort of move the projector, Bill, so that slides get on…

Carcinoid Tumors and the Carcinoid Syndrome: What’s new in the therapeutic pipeline

Presented by
Larry K. Kvols MD
Professor of Medicine
H. Lee Moffitt Cancer Center & Research Institute
Tampa, FL

Carcinoid Symposium 2002
Tampa, Florida
April 12-13, 2002

Dianne Comstock:

Our first speaker of the day is Dr. Larry Kvols who is accompanied…

Introduction to the Basic Science of Carcinoid

Presented by
Eugene A.Woltering MD FACS
The James D. Rives Professor of Surgery and Neurosciences Chief,
Section of Surgical Endocrinology,
Director Of Surgical Research
The Louisiana State University Heath Sciences Center
New Orleans La 70112

From…